Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Obstetrics and Gynecology|October 2, 2007
Risk of uterine rupture and adverse perinatal outcome at term after cesarean deliveryCatherine Y Spong, Mark B Landon, Sharon Gilbert, et al.Obstetrics and Gynecology|October 3, 2006
Blood transfusion and cesarean deliveryDwight J Rouse, Cora MacPherson, Mark Landon, et al.Obstetrics and Gynecology|December 7, 2007
Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveriesWilliam A Grobman, Rebecca Gersnoviez, Mark B Landon, et al.American Journal of Obstetrics and Gynecology|September 30, 2008
Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor?William A Grobman, Yinglei Lai, Mark B Landon, et al.Obstetrics and Gynecology|February 3, 2007
Outcomes of induction of labor after one prior cesareanWilliam A Grobman, Sharon Gilbert, Mark B Landon, et al.Obstetrics and Gynecology|June 2, 2006
Maternal morbidity associated with multiple repeat cesarean deliveriesRobert M Silver, Mark B Landon, Dwight J Rouse, et al.American Journal of Obstetrics and Gynecology|April 29, 2008
Prediction of uterine rupture associated with attempted vaginal birth after cesarean deliveryWilliam A Grobman, Yinglei Lai, Mark B Landon, et al.American Journal of Obstetrics and Gynecology|May 6, 2008
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placeboMark A Klebanoff, Paul J Meis, Mitchell P Dombrowski, et al.Obstetrics and Gynecology|March 4, 2008
Previous preterm cesarean delivery and risk of subsequent uterine ruptureAnthony C Sciscione, Mark B Landon, Kenneth J Leveno, et al.Obstetrics and Gynecology|September 2, 2005
Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis, Mark Klebanoff, Mitchell P Dombrowski, et al.Pageof 11